Alkondon M, Pereira EF, Todd SW, Randall WR, Lane MV, Albuquerque EX
(2015) Functional G-protein-coupled receptor 35 is expressed by neurons
in the CA1 field of the hippocampus. Biochem Pharmacol. 93:506-518.
Banerjee J, Alkondon M, Albuquerque EX (2012) Kynurenic acid inhibits
glutamatergic transmission to CA1 pyramidal neurons via a7
nAChR-dependent and -independent mechanisms. Biochem Pharmacol.
84:1078–1087.
Banerjee J, Banerjee Dixit A, Srivastava A, Ramanujam B, Kakkar A,
Sarkar C, Tripathi M, Chandra PS (2017) Altered glutamatergic tone
reveals two distinct resting state networks at the cellular level in
hippocampal sclerosis. Sci Rep. 7:319
Banerjee J, Banerjee Dixit A, Tripathi M, Sarkar C, Gupta YK, Chandra PS
(2015) Enhanced endogenous activation of NMDA receptors in pyramidal
neurons of hippocampal tissues from patients with mesial temporal lobe
epilepsy: A mechanism of hyper excitation. Epilepsy Res. 117:11-16.
Banerjee J, Dey S, Banerjee Dixit A, Tripathi M, Doddamani R, Sharma MC,
Chandra PS (2020) α7 nicotinic receptors contributes to glutamatergic
activity in the hippocampus of patients with mesial temporal lobe
epilepsy with hippocampal sclerosis (MTLE‑HS). J Neural Transm.
127:1441–1446.
Cabo R, Kozik K, Milanowski M, Hernes S, Slettan A, Haugen M, Ye S,
Blomhoff R, Mansoor MA (2014) A simple high-performance liquid
chromatography (HPLC) method for the measurement of
pyridoxal-5-phosphate and 4-pyridoxic acid in human plasma. Clin Chim
Acta. 433:150-156
Carpenedo R, Pittaluga A, Cozzi A, Attucci S, Galli A, Raiteriet M,
Moroni F (2001) Presynaptic kynurenate-sensitive receptors inhibit
glutamate release. Eur J Neurosci. 13:2141-2147.
de Moura, Tirapelli DP, Neder L, Saggioro FP, Sakamoto AC, Velasco TR,
Panepucci RA, Leite JP, Assirati Júnior JA, Colli BO, Carlotti Júnior CG
(2012) Amygdala gene expression of NMDA and GABA(A) receptors in
patients with mesial temporal lobe epilepsy. Hippocampus. 22:92-97
DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana
EM, Omiecinski CJ, Perdew GH (2010) Kynurenic acid is a potent
endogenous aryl hydrocarbon receptor ligand that synergistically induces
interleukin-6 in the presence of inflammatory signaling. Toxicol Sci.
115:89-97.
Engel J (2001) Mesial temporal lobe epilepsy: what have we learned?
Neuroscientist. 7:340-352.
Engel, J (2001) Mesial temporal lobe epilepsy: what have we learned?
Neuroscientist. 7:340-352.
Guillemin G, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, Croitoru
J, Brew BJ (2001) Kynurenine pathway metabolism in human astrocytes: a
paradox for neuronal protection. J Neurochem. 78:842–853.
Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque
EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic
receptor activity and increases non-alpha7 nicotinic receptor
expression: physiopathological implications. J Neurosci. 21:7463-7473.
Ito M, Seki T, Takuma, Y (2000) Current therapy of West syndrome in
Japan. J Child. Neurol. 15:424–428.
Jaeger B, Abeling NG, Salomons GS, Struys EA, Simas-Mendes M, Geukers
VG, Poll-The BT (2016) Pyridoxine responsive epilepsy caused by a novel
homozygous PNPO mutation. Mol Genet Metab Rep. 10:60-63.
Jallon P, Loiseau P, Loiseau J (2001) Newly diagnosed unprovoked
epileptic seizures: presentation at diagnosis in CAROLE study.
Coordination Active du Réseau Observatoire Longitudinal de l’ Epilepsie.
Epilepsia. 42:464-475.
Jin SH, Jeong W, Chung CK (2015) Mesial temporal lobe epilepsy with
hippocampal sclerosis is a network disorder with altered cortical hubs.
Epilepsia. 56:772–779.
Josephson CB, Dykeman J, Fiest KM, Liu X, Sadler RM, Jette N, Wiebe S
(2013) Systematic review and meta-analysis of standard vs selective
temporal lobe epilepsy surgery. Neurology. 80:1669-1676.
Kakkar A, Biswas A, Goyal N, Suri V, Sharma MC, Gupta D, Julka PK,
Sarkar C (2016) The Expression of Cyclin D1, VEGF, EZH2, and H3K27me3 in
atypical teratoid/rhabdoid tumors of the CNS: a possible role in
targeted therapy. Appl Immunohistochem Mol Morphol. 24:729-737.
Kamiński RM, Zielińska E, Dekundy A, van Luijtelaar G, Turski W (2003)
Deficit of endogenous kynurenic acid in the frontal cortex of rats with
a genetic form of absence epilepsy. Pol J Pharmacol. 55:741-746.
Kessler M, Terramani T, Lynch G, Baudry M (1989) A glycine site
associated with NMDA receptors: characterisation and identification of a
new class of antagonist. J Neurochem. 52:1319–1328.
Kuo MF, Wang HS (2002) Pyridoxal phosphate responsive epilepsy, with
resistance to pyridoxine. Pediatr Neurol. 26:146–147.
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauser WA, Mathern G, Moshé
SL, Perucca E, Wiebe S, French J (2010) Definition of drug resistant
epilepsy: consensus proposal by the ad hoc Task Force of the ILAE
Commission on Therapeutic Strategies. Epilepsia 51:1069-77.
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data
using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
Methods. 25:402-408.
Maciejak P. Szyndler J, Turzyńska D, Sobolewska A, Taracha E, Skórzewska
A, Lehner M, Bidziński A, Płaźnik A (2008) Time course of changes in the
concentration of kynurenic acid in the brain of
pentylenetetrazol-kindled rats. Brain Res Bull. 78:299-305.
Moroni F, Cozzi A, Sili M, Mannaioni G (2012) Kynurenic acid: a
metabolite with multiple actions and multiple targets in brain and
periphery. J Neural Transm. 119:133–139.
Musayev FN, Di Salvo ML, Saavedra M, Contestabile R, Ghatke M, Haynes A,
Schirch V, Safo MK (2009) Molecular basis of reduced pyridoxine
5′-phosphate oxidase catalytic activity in neonatal epileptic
encephalopathy disorder. J Biol Chem. 284:30949–30956.
Nürnberger S, Lindner C, Maier J, Strohmeier K, Wurzer C, Slezak P,
Suessner S, Holnthoner W, Redl H, Wolbank S, Priglinger E (2019)
Adipose-tissue-derived therapeutic cells in their natural environment as
an autologous cell therapy strategy: the microtissue-stromal vascular
fraction. Eur Cell Mater. 37:113-133
Parsons CG, Danysz W, Quack G, Hartmann S, Lorenz B, Wollenburg C, Baran
L, Przegalinski E, Kostowski W, Krzascik P, Chizh B, Headley PM (1997)
Novel systemically active antagonists of the glycine site of the
N-methyl-D-aspartate receptor: electrophysiological, biochemical and
behavioral characterization. J Pharmacol Exp Ther. 283:1264–1275
Perkins M, Stone T (1984) Actions of excitatory amino acids and
kynurenic acid in the primate hippocampus: A preliminary study. Neurosci
Lett. 52:335-340.
Pocivavsek A, Wu HQ, Potter MC, Elmer GI, Pellicciari R, Schwarcz R
(2011) Fluctuations in endogenous kynurenic acid control hippocampal
glutamate and memory. Neuropsychopharmacology. 36:2357-2367.
Potter M, Elmer G, Bergeron R, Albuquerque E, Guidetti P, Wu H, Schwarcz
R (2010) Reduction of endogenous kynurenic acid formation enhances
extracellular glutamate, hippocampal plasticity, and cognitive behavior.
Neuropsychopharmacology. 35:1734-1742.
Rassoulpour A, Wu HQ, Ferré S, Schwarcz R (2005) Nanomolar
concentrations of kynurenic acid reduce extracellular dopamine levels in
the striatum. J Neurochem. 93:762–765.
Roy S, Sharma HP, Nag TC, Velpandian T, Upadhyay AD, Mathur R, Jain S
(2014) BDNF mediated activity dependent maturation of visual Wulst
following prenatal repetitive auditory stimulation at a critical
developmental period in domestic chicks (Gallus domesticus). Brain Res
Bull. 109:99-108.
Scharfman HE (2007) The neurobiology of epilepsy. Curr Neurol Neurosci.
Rep. 7:348-354.
Schwarcz R, Bruno J, Muchowski P, Wu H (2012) Kynurenines in the
mammalian brain: when physiology meets pathology. Nat Rev Neurosci.
13:465-477.
Szyndler J, Maciejak P, Turzyńska D, Sobolewska A, Walkowiak J, Płaźnik
A (2012) The effects of electrical hippocampal kindling of seizures on
amino acids and kynurenic acid concentrations in brain structures. J
Neural Transm. 119:141-149.
Tripathi M, Ray S, Chandra PS (2016) Presurgical evaluation for drug
refractory epilepsy. Int J Surg. 36:405-410.
Turski WA, Gramsbergen JB, Traitler H, Schwarcz R (1989) Rat Brain
Slices Produce and Liberate Kynurenic Acid upon Exposure to
L-Kynurenine. J Neurochem. 52:1629-1636.
Watanabe K (1995) Medical treatment of West syndrome in Japan. J Child
Neurol. 10:143–147.
Wu H, Turski W, Ungerstedt U, Sahwarcz R (1991) Systemic Kainic Acid
Administration in Rats: Effects on Kynurenic Acid Production in Vitro
and in Vivo. Exp Neurol. 113:47-52.
Xiao LD, Luo XB, Pi LG, Tang AG (2008) Simultaneous determination of
kynurenine and kynurenic acid concentrations in human serum by HPLC with
dual wavelengths fluorescence detection. Clin Chim Acta. 395:178-180
Yamamoto H, Murakami H, Horiguchi K, Egawa B (1995) Studies on
cerebrospinal fluid kynurenic acid concentrations in epileptic children.
Brain Dev. 17:327-329.
Yamamoto H, Shindo I, Egawa B, Horiguchi K (1994) Kynurenic acid is
decreased in cerebrospinal fluid of patients with infantile spasms.
Pediatr Neurol. 10:9-12.